Home  /  Resource Library  /  Off-the-Shelf CAR T-Cell Therapy Shows Promise in Relapsed/Refractory B-Cell Lymphomas

Off-the-Shelf CAR T-Cell Therapy Shows Promise in Relapsed/Refractory B-Cell Lymphomas

ASCO 2020: Intial results of a phase I study investigating CAR T therapy ALLO-501 combined with monoclonal antibody ALLO-647 for treatment of relapsed diffuse large b-cell and follicular lymphomas.